Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Revive Therapeutics Ltd.
C.RVV
Alternate Symbol(s):
RVVTF
Healthcare
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is...
advancing the development of Psilocybin-based therapeutics in various diseases and disorders. The Company’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted Food and Drug Administration (FDA) orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:RVV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(42)
•••
cool888
X
View Profile
View Bullboard History
Comment by
cool888
on Oct 18, 2022 9:00pm
RE:RE:We need this
If that's the case, why you idiot(s) still here - just dunp morons.... shorts? !!!
(163)
•••
MyAli4s
X
View Profile
View Bullboard History
Comment by
MyAli4s
on Oct 18, 2022 8:48am
RE:We need this
If BUC had any effect on covid, it would be known already!
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA
posted Apr 25, 2024 9:00am by
Indiva Ltd
-
|
“Net Income was just shy of break-even in Q4, which is a testament to the popularity of our products, our industry leading low-cost production platform, and our focus on cost control. Our core brands, namely Pearls by Grön, No Future, Bhang Chocolate and Indiva Blips continue to gain market share in Canada, as Indiva continues to hold the #1 market share position in edibles nationally," said ...read more
(37)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Post by
ENEMENEMYNEMO
on Oct 17, 2022 9:35am
We need this
Man, the world needs a drug to combat symptoms and reduce spread...fingers crossed on BUC being the one! https://apple.news/Ar-DS_L-FS0ql2kVzXdCH8Q
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Oct 16, 2022 8:11pm
Some Personal Thoughts on Recent Revive Developments !
#Bucillamine Thanks BobsterWat !! https://www.reddit.com/r/RVVTF/comments/y5ouow/some_personal_thoughts_on_recent_revive/
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Oct 15, 2022 9:31pm
BMT's comments re: Primary symptoms endpoint
#Bucillamine https://www.reddit.com/r/RVVTF/comments/y4r13p/primary_symptoms_endpoint/
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Oct 15, 2022 8:19pm
PR firm that represents Pfizer and Moderna also sits on CDC
https://www.dailymail.co.uk/health/article-11303017/PR-firm-represents-Pfizer-Moderna-sits-CDC-vaccine-advisory-committee.htm
(12)
•••
DehydraTECH
X
View Profile
View Bullboard History
Post by
DehydraTECH
on Oct 14, 2022 5:26pm
When 3 pennies
https://nationalpost.com/health/canada-covid-19-drug-merck-independent-trial
(23)
•••
hk1966
X
View Profile
View Bullboard History
Comment by
hk1966
on Oct 14, 2022 4:18pm
RE:Fda loves to waste Canucks time
So true.. to borrow a phrase from Shaft 2000... "no malt liquor" ie. "no maple syrup aka no Canadians allowed"
(36)
•••
WeedKing81
X
View Profile
View Bullboard History
Post by
WeedKing81
on Oct 14, 2022 2:15pm
Update looks good 👍
https://www.globenewswire.com/news-release/2022/10/14/2534882/0/en/Revive-Therapeutics-Announces-Finalization-of-Amended-Phase-3-COVID-19-Study-Protocol-to-FDA.html
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Oct 14, 2022 1:54pm
$RVV $RVVTF - Update !
#Bucillamine https://finance.yahoo.com/news/revive-therapeutics-announces-finalization-amended-173400585.html
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 14, 2022 1:34pm
New Press Release - Revive Therapeutics Announces Finalization of Amended Phase 3 COVID-19 Study Protocol to FDA
TORONTO, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced today that it has...
read article.
(12)
•••
DehydraTECH
X
View Profile
View Bullboard History
Post by
DehydraTECH
on Oct 13, 2022 11:19pm
Fda loves to waste Canucks time
Going to be delay after delay And before you know it Michael Frank will be buying this stock at 3 cents again with a 10 to 1 reverse split
(36)
•••
WeedKing81
X
View Profile
View Bullboard History
Post by
WeedKing81
on Oct 11, 2022 11:58am
LETS GO RVV!! 😀
https://ceo.ca/BUCILLAMINE
(36)
•••
WeedKing81
X
View Profile
View Bullboard History
Post by
WeedKing81
on Oct 11, 2022 11:57am
BUY THE DIPS AND HOLD. $$$
https://ceo.ca/BUCILLAMINE
(31)
•••
TheTerminator1
X
View Profile
View Bullboard History
Comment by
TheTerminator1
on Oct 09, 2022 7:34am
RE:Enjoy the long weekend ! Checkout these stocks, do UR DD !
Here is a guy who just finished loading up on a bunch of penny stocks...Pump away little man :)
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil
Stage Set for Creation of a Leading Intermediate Gold Producer
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Discover a Green Resources Stock Scoring Record Quarterly Growth